乳腺癌预测和预后标志物的技术方面:英国NEQAS数据显示

Keith Miller , Merdol Ibrahim , Sarah Barnett , Bharat Jasani
{"title":"乳腺癌预测和预后标志物的技术方面:英国NEQAS数据显示","authors":"Keith Miller ,&nbsp;Merdol Ibrahim ,&nbsp;Sarah Barnett ,&nbsp;Bharat Jasani","doi":"10.1016/j.cdip.2006.12.003","DOIUrl":null,"url":null,"abstract":"<div><p>Predictive and prognostic testing for breast cancer is now an important part of cellular pathology. The UK National External Quality Assessment Scheme (NEQAS) for immunocytochemistry and fluorescent in situ hybridization plays a significant role in ensuring that the quality of testing meets the clinical standards required, by assessing the performance of each participant laboratory every 3 months. Besides receiving a confidential performance report, data on the methods used are collected, analysed against the scores and published in the UK NEQAS journal. This information is intended to help those who are not achieving the best scores to improve their performance.</p></div>","PeriodicalId":87954,"journal":{"name":"Current diagnostic pathology","volume":"13 2","pages":"Pages 135-149"},"PeriodicalIF":0.0000,"publicationDate":"2007-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.cdip.2006.12.003","citationCount":"14","resultStr":"{\"title\":\"Technical aspects of predictive and prognostic markers in breast cancer: What UK NEQAS data shows\",\"authors\":\"Keith Miller ,&nbsp;Merdol Ibrahim ,&nbsp;Sarah Barnett ,&nbsp;Bharat Jasani\",\"doi\":\"10.1016/j.cdip.2006.12.003\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><p>Predictive and prognostic testing for breast cancer is now an important part of cellular pathology. The UK National External Quality Assessment Scheme (NEQAS) for immunocytochemistry and fluorescent in situ hybridization plays a significant role in ensuring that the quality of testing meets the clinical standards required, by assessing the performance of each participant laboratory every 3 months. Besides receiving a confidential performance report, data on the methods used are collected, analysed against the scores and published in the UK NEQAS journal. This information is intended to help those who are not achieving the best scores to improve their performance.</p></div>\",\"PeriodicalId\":87954,\"journal\":{\"name\":\"Current diagnostic pathology\",\"volume\":\"13 2\",\"pages\":\"Pages 135-149\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2007-04-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1016/j.cdip.2006.12.003\",\"citationCount\":\"14\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Current diagnostic pathology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0968605306001281\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current diagnostic pathology","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0968605306001281","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 14

摘要

乳腺癌的预测和预后检测现在是细胞病理学的重要组成部分。免疫细胞化学和荧光原位杂交的英国国家外部质量评估计划(NEQAS)通过每3个月评估每个参与实验室的表现,在确保检测质量满足临床标准要求方面发挥了重要作用。除了收到一份保密的绩效报告外,还收集了所使用方法的数据,并根据分数进行分析,并在英国NEQAS期刊上发表。这些信息是为了帮助那些没有达到最好成绩的人提高他们的表现。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Technical aspects of predictive and prognostic markers in breast cancer: What UK NEQAS data shows

Predictive and prognostic testing for breast cancer is now an important part of cellular pathology. The UK National External Quality Assessment Scheme (NEQAS) for immunocytochemistry and fluorescent in situ hybridization plays a significant role in ensuring that the quality of testing meets the clinical standards required, by assessing the performance of each participant laboratory every 3 months. Besides receiving a confidential performance report, data on the methods used are collected, analysed against the scores and published in the UK NEQAS journal. This information is intended to help those who are not achieving the best scores to improve their performance.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信